Immunic IMUX
NASDAQ IMUX
$8.12 +0.08 (+1.00%)
At close: Nov 11, 2026 · 4:00 PM EST

Immunic (IMUX) Return on Capital Employed [ROCE] (2014 - 2026)

Updated

Immunic (IMUX) posted Return on Capital Employed [ROCE] of -82.32% for Q2 2026, up 688.34 percentage points from -770.66% a year earlier and up 77.65 percentage points from the prior quarter.

Analysis

Immunic (IMUX) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends

For FY2025, Immunic's Return on Capital Employed [ROCE] came in at -5604.13%, down 5218.22 percentage points from FY2024.

  • Annual Return on Capital Employed [ROCE] has declined for five consecutive years, with a five-year change of -5559.00 percentage points (FY2020 to FY2025).
  • In prior years, Immunic's Return on Capital Employed [ROCE] was -385.90% in FY2024 (-236.24 pp), -149.66% in FY2023 (-50.38 pp), -99.28% in FY2022 (-34.77 pp) and -64.52% in FY2021 (-19.39 pp).
  • The Q2 2026 figure stands as the highest quarterly Return on Capital Employed [ROCE] since Q3 2022.
  • On a year-over-year basis, Return on Capital Employed [ROCE] increased in three of the last eight quarters, with an average year-over-year change of -727.65 percentage points.
  • The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2026, with a gain of 1820.53 percentage points; the weakest was Q4 2025, with a drop of 5545.21 percentage points.
  • According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -159.98% (Q1 2026), -5865.23% (Q4 2025) and -502.83% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 35.41%
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 17.52%
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 21.60%
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 4.65%
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 9.91%
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 17.37%
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -6.15%
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 11.32%
10 Immunic 341.81 Mn -50.53 Mn - -82.32%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -82.32%
Mar 31, 2026 -159.98%
Dec 31, 2025 -5,865.23%
Sep 30, 2025 -502.83%
Jun 30, 2025 -770.66%
Mar 31, 2025 -1,980.51%
Dec 31, 2024 -320.01%
Sep 30, 2024 -183.28%
Jun 30, 2024 -128.91%
Mar 31, 2024 -162.24%
Dec 31, 2023 -276.32%
Sep 30, 2023 -221.66%
Jun 30, 2023 -161.01%
Mar 31, 2023 -122.83%
Dec 31, 2022 -107.32%
Sep 30, 2022 -70.87%
Jun 30, 2022 -61.36%
Mar 31, 2022 -60.66%
Dec 31, 2021 -67.14%
Sep 30, 2021 -61.95%
API Access

Immunic Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=IMUX&period=max&api_key=YOUR_API_KEY